Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, pain management, pre-term labor, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was incorporated in 1944 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.
P/E ratio for Abbott India Limited (ABBOTINDIA.NS)
P/E ratio as of 2023: 48.68
According to Abbott India Limited's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 48.68. At the end of 2022 the company had a P/E ratio of 49.38.
P/E ratio history for Abbott India Limited from 2004 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | 48.68 |
| 2022 | 49.38 |
| 2021 | 47.10 |
| 2020 | 46.10 |
| 2019 | 55.37 |
| 2018 | 34.43 |
| 2017 | 29.08 |
| 2016 | 35.66 |
| 2015 | 38.51 |
| 2014 | 36.68 |
| 2013 | 22.37 |
| 2012 | 21.75 |
| 2011 | 25.78 |
| 2010 | 45.68 |
| 2009 | 22.12 |
| 2008 | 27.27 |
| 2007 | 25.06 |
| 2006 | 28.64 |
| 2005 | 28.98 |
| 2004 | 16.77 |